UBS Group’s SOC Telemed, Inc. Warrants TLMDW Stock Holding History

UBS Group’s Portfolio TLMDW Stock Details TLMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-16,410	Closed	-$2K	–	11481
2021 Q4	$2K	Buy	+16,410	New	+$4.53K	﹤0.01%	9932

Other funds holding TLMDW

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Antara Capital New York $30.2K AUM 5.24% 1-Year Est. Return

ICM

Ionic Capital Management New York $690M AUM 70.34% 1-Year Est. Return

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

TCM

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

UBS Group's TLMDW Position: Q1 2022 in Review

UBS Group sold out of SOC Telemed, Inc. Warrants (TLMDW) in Q1 2022, closing a stake of 16,410 shares — an estimated $2K sold.

UBS Group first reported a position in TLMDW in Q4 2021 and held it in 1 quarter. The position peaked at $2K in Q4 2021. 13 funds tracked by Wall St. Rank hold TLMDW as of Q1 2022.

UBS Group reported no remaining SOC Telemed, Inc. Warrants position as of Q1 2022 after selling out during the quarter.
UBS Group sold 16,410 SOC Telemed, Inc. Warrants shares in Q1 2022, an estimated $2K.
UBS Group first reported a position in SOC Telemed, Inc. Warrants in Q4 2021 and held it in 1 quarter.
UBS Group's SOC Telemed, Inc. Warrants position peaked at $2K in Q4 2021.
13 funds tracked by Wall St. Rank held SOC Telemed, Inc. Warrants as of Q1 2022.

Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.